Despite attempts to improve treatment over the last few decades, children with advanced neuroblastoma or muscle or bone sarcoma continue to die from their disease. New treatments are sorely needed. Therapies that utilize the immune system to fight cancer, such as use of immune cells called natural killer (NK) cells, have shown promise in the lab. Their ability to cure patients, however, has been limited by a powerful tumor environment that inhibits the immune system.